• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Cardiome Pharma’s Xydalba treatment for ABSSSI available in UK pharmaceutical-technology
    June 27, 2017
    Canadian pharmaceutical company Cardiome Pharma’s new intravenous (IV) antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults, known as Xydalba (dalbavancin hydrochloride), has been made available in the UK.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service